Clinical Trials Browser

Phase 4 × anlotinib × Sarcoma × Clear all

NCT06506838 2024-08-12

Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma

Phase 4 Recruiting

Sarcoma